Clinical Trial Update: A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating clevudine as monotherapy or in combination with adefovir for chronic hepatitis B has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Clevudine (clevudine)
• Hepsera (adefovir dipivoxil)

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: Chronic Hepatitis B | Phase 4 | Status: TERMINATED